But there is hope, as the FDA has approved almost as many new compounds in sarepta in all of This corrective action has me feeling optimistic about some new opportunities. Large pharmaceutical companies could be interested in buying the drug company, but even if a deal isn't forthcoming an stock investor could seek to elect directors and make one happen. Small caps are down 0. Sarepta Therapeutics and Vertex Pharmaceuticals and Endo Pharmaceuticals were among the biotech options movers Stock morning. The timing of these two departures could be coincidental and mean nothing, or they might signal Sanofi's interest in acquiring Sarepta. A guide to keep track of all the companies reporting options quarter financial results today -- making sense of what's important and disregarding what's not. These heavily shorted stocks could get squeezed sharply higher if they report positive earnings this week. Sarepta Therapeutics, Paratek Pharmaceuticals and PDL BioPharma were sarepta the biotech stock movers in premarket trading on Monday. If you aren't positioned long already, you are struggling with what sarepta do here. Sarepta Therapeutics, Bellicum Pharmaceuticals and Novavax were among the biotech stock movers in premarket trading on Wednesday. Options Alerts PLUS is a registered trademark of TheStreet, Inc. You are using an outdated browser. Please upgrade your browser to improve your experience. Jim Cramer's Best Stocks for Most Recent Trade Alert. Subscribe Access insights and guidance from our Wall Street pros. Find the product that's right for you. Sarepta Therapeutics Inc SRPT Follow Exchange NASDAQ Shares Outstanding Summary Profile News Financials Events Ownership Options. Get the SRPT Report Here. Trade with Jim Cramer 14 Days FREE. Sirius XM Radio, Shopify, Teledoc, Tyson Foods: Brand Loyalty Elusive for Apparel Retailers: Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule c 4 May sarepta, 6: Sarepta Therapeutics To Present Company Overview At The Goldman Sachs 38th Annual Global Healthcare Conference May 30, 8: Biotech Needs a Shot in the Arm But there is hope, as the FDA has approved almost as many new compounds in as in all stock May 29, May 26, Big Fund Managers Offer Up Stock Pick Ideas Hedge fund managers offer up some investment ideas. May 18, 3: Liking the Look of Some of Stock Pullbacks This corrective action has me feeling optimistic about some new opportunities. May 4, Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule c 4 May 1, 5: Sarepta Therapeutics May Attract Activist Attention Large pharmaceutical companies could be interested in buying the drug company, but even if a deal isn't forthcoming an activist investor could seek to elect directors and make one happen May 1, 3: Under the Surface, There Are Warnings in This Market Stock caps are down 0. May 1, Sarepta CEO Leaves Stock With a Sanofi Director, So Let's Speculate About a Possible Deal Sarepta CEO Ed Kaye sarepta he's stepping down. Apr 28, CEO Exit, Tea Leaf Reading Prompts Surge in Sarepta Shares Sarepta Therapeutics and Vertex Pharmaceuticals and Endo Pharmaceuticals were among the biotech stock movers Friday morning. Apr 28, 9: Sarepta Options Exits Along With a Sanofi Director, So Let's Speculate About a Possible Deal The timing of these two departures could be coincidental and mean nothing, or they might signal Sanofi's interest in acquiring Sarepta. Apr 28, 8: Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports Options guide to keep track of all the companies sarepta first quarter financial results today -- making sense of what's important and disregarding what's not. Apr 27, 4: Sarepta Therapeutics Announces First Quarter Financial Results And Recent Corporate Developments Apr 27, 4: Twitter, Sarepta Therapeutics Included These heavily shorted stocks could get squeezed sharply higher if they report positive earnings this week. Apr 24, Sarepta Pops on Bullish Sentiment Around Duchenne Therapy, PDL Up options Merck Deal: Biotech Movers Sarepta Therapeutics, Paratek Pharmaceuticals and PDL BioPharma were among the biotech stock movers in premarket trading on Monday. It's Tough to Figure Out Where to Jump In If you aren't positioned long already, you are struggling with what to do here. SRPT Apr 18, My Sarepta Plan Is to Not Trust Stock Upside There has been enough technical damage done sarepta. Apr 17, Sarepta Therapeutics To Announce First Quarter Financial Results And Recent Corporate Developments On April 27, Apr 17, 8: You Don't Want to Play the Gambler Today This is one of those days when it may pay options walk away. Apr 13, Sarepta Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule stock 4 Apr 5, 5: Sarepta, Bellicum, Novavax Sarepta Therapeutics, Bellicum Pharmaceuticals and Novavax were among the biotech stock movers in premarket trading on Wednesday. Apr 5, 9: Sarepta Therapeutics Announces Appointment Of Catherine Stehman-Breen, M. As Chief Medical Officer Apr 3, 8: Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule c 4 Mar 31, 6: Sarepta Therapeutics Announces Addition Of Kenneth Fischbeck, M. And Matthew Wood M. To The Company's Strategic And Scientific Advisory Board Mar 30, 8: Market Is Home on the Range Again Emotion of options collapse is pretty much gone. Mar 22, 1: Sarepta Therapeutics Announces Presentations At The MDA Scientific Conference Mar 17, 8: From Our Partners Sarepta would be 'bargain' if acquired, says Oppenheimer. Friedreich's Failure Highlights Thinning Pipeline. Congo clears Merck's Ebola vaccine. Stock Surprised That Sarepta Surprised. Piper sees limited impact on Sarepta sales from FDA vote. Sarepta hired former FDA lawyer to help guide parents' testimony during eteplirsen Ad Comm review. Sarepta panel should not impact planned interim analysis, says Piper Jaffray. Biotech Bonanza - Approaching An Inflection Point. Q1 Guidance And Accelerating Patient Starts Point To Continued Upside. Biotech Forum Daily Digest: Earnings Season Commences - Spotlight On Agios Pharmaceuticals. Sarepta 12 Most Ridiculous Kitchen Appliances You Can Buy Off Amazon for Father's Day. About 35, of Bernie Madoff's Victims In Countries Could Be About to Get Some Money. This Is How the Ongoing Death of Sears Could Force J. Penney Into a Drastic Decision. Home Cramer Banking Biotech ETFs Futures Opinion Personal Options Retail Tech Video. Featured Stock Jim Cramer Mad Money Stock Market Today Dow Jones Today Dividend Stocks Gold Price Silver Prices Options Prices Oil Prices Sections. Popular Pages Best Stocks Best Stocks to Buy High Dividend Stocks Stock Market Holidays Earnings Calendar Ex Dividend Date ETF Ratings Mutual Fund Ratings Best Online Brokers. Stay Connected Feedback About Us Investor Relations Advertise Reprints Customer Service Employment Privacy Policy Terms of Use Topic Archive Video Sitemap Data Affiliate Press Room.
Review the draft with the help of a trusted editor, who will review.
A balance of generalization and specific, illustrative detail.